Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)
Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Mycophenolate mofetil added to immunosuppressive treatment regimens may be
effective in treating newly diagnosed chronic graft-versus-host disease caused by stem cell
transplantation. It is not yet known whether immunosuppressive treatment regimens are more
effective with or without mycophenolate mofetil in treating chronic graft-versus-host
disease.
PURPOSE: This randomized phase III trial is studying whether the addition of mycophenolate
mofetil improves the efficacy of immunosuppressive treatment regimens in patients with newly
diagnosed chronic graft-versus-host disease.